Healthy Skepticism Library item: 5895
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: media release
Steinman M.
I am pleased to announced the existence of the Drug Industry Document Archive, a new online archive of documents that describes drug industry marketing.
Drug Industry Document Archive 2006 Aug 17
http://dida.library.ucsf.edu
Full text:
In conjunction with an article published yesterday in Annals of Internal
Medicine, I am pleased to announced the existence of the Drug Industry
Document Archive, a new online archive of documents that describe drug
industry marketing.
The archive, hosted by the UCSF library and available at
http://dida.library.ucsf.edu, contains electronically indexed and
searchable documents obtained from litigation alleging off-label marketing
of gabapentin (Neurontin), and documents about the marketing of rofecoxib
(Vioxx). These documents include internal company correspondence, budget
spreadsheets, strategy reports, payment registers, and other material that
describes marketing practices. We hope to expand this archive to include
documents obtained from other litigation.
We encourage researchers, educators, and others to use the archive for
scholarly research and for educational programs about drug industry
marketing. People interested in this topic may also find it valuable just
to skim the contents. Several features of the archive facilitate either a
quick skim or in-depth study.
For any questions, please feel free to contact me or contact the archive
staff directly through the “contact us” link on the website.
Yours,
Mike Steinman
Michael Steinman, MD
Assistant Professor of Medicine in Geriatrics
San Francisco VA Medical Center and UCSF
Tel: 415.221.4810 ×3677
Fax: 415.750.6641
Email: mike.steinman@ucsf.edu
Any opinions expressed in this message are mine and do not reflect
positions of the government or the Department of Veteran Affairs